-
1 Comment
Bio-Rad Laboratories, Inc is currently in a long term uptrend where the price is trading 16.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.
Bio-Rad Laboratories, Inc's total revenue rose by 26.5% to $790M since the same quarter in the previous year.
Its net income has increased by 51.6% to $839M since the same quarter in the previous year.
Finally, its free cash flow grew by 77.6% to $245M since the same quarter in the previous year.
Based on the above factors, Bio-Rad Laboratories, Inc gets an overall score of 5/5.
Industry | Medical Devices |
---|---|
Sector | Healthcare |
ISIN | US0905722072 |
CurrencyCode | EUR |
Exchange | F |
Beta | 0.93 |
---|---|
Dividend Yield | 0.0% |
Target Price | 856.25 |
PE Ratio | None |
Market Cap | 13B |
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BUWA.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024